Jefferies Financial Group Inc. Has $16.18 Million Stock Holdings in Cardinal Health, Inc. $CAH

Jefferies Financial Group Inc. raised its position in Cardinal Health, Inc. (NYSE:CAH) by 43.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,736 shares of the company’s stock after buying an additional 23,788 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Cardinal Health were worth $16,180,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Aventura Private Wealth LLC acquired a new position in Cardinal Health in the 4th quarter valued at $25,000. Elyxium Wealth LLC acquired a new position in Cardinal Health in the 4th quarter valued at $34,000. Barnes Dennig Private Wealth Management LLC grew its holdings in Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after buying an additional 53 shares in the last quarter. JPL Wealth Management LLC acquired a new position in Cardinal Health in the 3rd quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in Cardinal Health in the 3rd quarter valued at $31,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

NYSE:CAH opened at $200.42 on Monday. The stock has a fifty day moving average price of $205.21 and a 200-day moving average price of $208.82. The company has a market cap of $46.94 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.

Analysts Set New Price Targets

A number of research analysts have commented on CAH shares. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Robert W. Baird set a $248.00 target price on Cardinal Health in a research report on Friday, May 1st. Evercore cut their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Wells Fargo & Company cut their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Mizuho upped their target price on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.